Seminars in Fetal & Neonatal Medicine
Volume 12, Issue 2 , Pages 114-118 , April 2007

Management of women who use drugs during pregnancy

  • Alison Wright

      Affiliations

    • Department of Obstetrics and Gynaecology, Leeds Teaching Hospitals NHS Trust, Clarendon Wing, Leeds General Infirmary, Belmont Grove, Leeds LS2 9NS, UK
    • Corresponding Author InformationCorresponding author. Tel.: +44 113 243 2799.
    • ,
  • James Walker

      Affiliations

    • University Department of Obstetrics and Gynaecology, Leeds Teaching Hospitals NHS Trust, Leeds, UK

References 

  1. Berghella V, Lim PJ, Cherpes J, Chennat J, Kaltanbach K. Maternal methadone dose and neonatal withdrawal. Am J Obstet Gynaecol. 2003;189(2):312–317
  2. Fajemirokun-Odudeyi O, Sinha C, Tutty S, Pairaudeau P, Armstrong D, Phillips T, et al. Pregnancy outcome in women who use opiates. Eur J Obstet Gynecol Reprod Biol. 2006;126(2):170–175[Epub 2005 oct 3]
  3. Kennare R, Heard A, Chan A. Substance use during pregnancy: risk factors and obstetric and perinatal outcomes in South Australia. Aust NZ J Obstet Gynaecol. 2005;45(3):220–225
  4. Singer R, Ben-Bassat M, Malik Z, Sagiv M, Ravid A, Shohat B, et al. Oligozoospermia, asthenozoospermia, and sperm abnormalities in ex-addict to heroin, morphine, and hashish. Arch Androl. 1986;16(2):167–174
  5. Ragni G, De Lauretis L, Gambaro V, Di Pietro R, Bestetti O, Recalcati F, et al. Semen evaluation in heroin and methadone addicts. Acta Eur Fertil. 1985;16(4):245–249
  6. Bellati U, Noia G, Conte M, Mazzei R. Tempesta E Amenorrhea in drug dependence. Minerva Med. 1983;74(16):865–868
  7. Schmittner J, Schroeder JR, Epstein DH, Preston KL. Menstrual cycle length during methadone maintenance. Addiction. 2005;100(6):829–836
  8. Tonkiss J, Harrison RH, Galler JR. Differential effects of prenatal protein malnutrition and prenatal cocaine on a test of homing behavior in rat pups. Physiol Behav. 1996;60(3):1013–1018
  9. Lundsberg LS, Bracken MB, Saftlas AF. Low-to-moderate gestational alcohol use and intrauterine growth retardation, low birthweight, and preterm delivery. Ann Epidemiol. 1997;7(7):498–508
  10. Adriaanse HP, Knottnerus JA, Delgado LR, Cox HH, Essed GGM. Smoking in Dutch pregnant women and low birthweight. Patient Educ Counsel. 1996;28:25–30
  11. Nieto A, Matorras R, Serra M, Valenzuela P, Molero J. Multivariate analysis of determinants of fetal growth retardation. Eur J Obstet Gynaecol Reprod Biol. 1994;53:107–113
  12. Campion P, Owen L, Mcneill A, Mcguire C. Evaluation of a mass media campaign on smoking and pregnancy. Addiction. 1994;89:1245–1254
  13. Schneider C, Fischer G, Diamant K, Hauk R, Pezawas L, Lenzinger E, et al. Pregnancy and Drug abuse. Wiener Klin Wochenschr. 1996;108:611–614
  14. Sprauve ME, Lindsay MK, Herbert S, Graves W. Adverse perinatal outcome in parturients who use crack cocaine. Obstet Gynecol. 1997;89(5 Pt 1):674–678
  15. Eyler FD, Behnke M, Conlon M, Woods NS, Wobie K. Birth outcome from a prospective, matched study of prenatal crack/cocaine use: I. Interactive and dose effects on health and growth. Paediatrics. 1994;101(2):229–237
  16. Lam SK, To WK, Duthie SJ, Ma HK. Narcotic addiction in pregnancy with adverse maternal and perinatal outcome. Aust NZ J Obstet Gynaecol. 1992;32(3):216–221
  17. Bada HS, Das A, Bauer CR, Shankaran S, Lester BM, Gard CC, et al. Low birthweight and preterm births: etiologic fraction attributable to prenatal drug exposure. J Perinatol. 2005;25(10):631–637
  18. Weber JC, Kopferschmitt J. Substitution therapy of drug addicts. Presse Med. 1998;27(39):2088–2209
  19. Dashe JS, Sheffield JS, Olscher DA, Todd SJ, Jackson GL, Wendel GD. Relationship between maternal methadone dosage and neonatal withdrawal. Obstet Gynecol. 2002;100(6):1244–1249
  20. Department of Health. Instalment prescribing of buprenorphine for the treatment of drug addiction [12 March 2001].
  21. Marquet P, Chevrel J, Lavignasse P, Merle L, Lachatre G. Buprenorphine withdrawal syndrome in a newborn. Clin Pharmacol Ther. 1997;62:569–571
  22. Johnson RE, Svikis DS, Kissin WB. Pilot open label, safety study of buprenorphine during pregnancy. College on Problems of Drug Dependence. 1998;[Abstract 68]
  23. Fischer G, Johnson RE, Eder H, Jagsch R, Peternell A, Weninger M, et al. Treatment of opioid-dependent pregnant women with buprenorphine. Addiction. 2000;95(2):239–244
  24. Jones HE, Johnson RE, Jasinski DR, Milio L. Randomized controlled study transitioning opioid-dependent pregnant women from short-acting morphine to buprenorphine or methadone. Drug Alcohol Depend. 2005;79(1):1–10
  25. Fischer G, Ortner R, Rohrmeister K, Jagsch R, Baewert A, Langer M, et al. Methadone versus buprenorphine in pregnant addicts: a double-blind, double-dummy comparison study. Addiction. 2006;101(2):275–281

PII: S1744-165X(07)00006-6

doi: 10.1016/j.siny.2007.01.001

Seminars in Fetal & Neonatal Medicine
Volume 12, Issue 2 , Pages 114-118 , April 2007

Article Tools